US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

34.82

+0.41351.20%

Post-market: 34.820.00000.00%16:10 EDT

Volume:2K

Turnover:58.72K

Market Cap:13.93M

PE:- -

High:34.86

Open:34.76

Low:34.76

Close:34.41

52wk High:34.86

52wk Low:25.79

Shares:400.00K

Float Shares:400.00K

Volume Ratio:0.42

T/O Rate:0.42%

Dividend:0.08

Dividend Rate:0.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Jiangsu Hengrui Pharma Secures Clinical Trial Approval for Innovative Multi-Peptide Drug HRS-4729 Injection

Chengdu Easton Biopharma Subsidiary Initiates Phase I/II Trial for Novel Lymphoma Drug, First Patient Dosed

Haisco Pharmaceutical Group Receives Clinical Trial Approval for Novel Drug HSK60002 Tablet

MacroGenics Rises on $10 Million Milestone Payment from Gilead

Edwards Lifesciences CVP TAVR Daniel J. Lippis Melepas 619 Saham Senilai $ 56.966,57

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BMED/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":34.8186,"timestamp":1787688000000,"preClose":34.4051,"halted":0,"volume":1685,"hourTrading":{"tag":"盘后","latestPrice":34.8186,"preClose":34.8186,"latestTime":"16:10 EDT","volume":6,"amount":208.83439799999996,"timestamp":1787688604015,"change":0,"changeRate":0,"amplitude":0.001109},"delay":0,"changeRate":0.012018567014774153,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"Post-Mkt","change":0.4135,"latestTime":"08-25 17:26:55 EDT","open":34.76,"high":34.86,"low":34.76,"amount":58719,"amplitude":0.002907,"askPrice":52.21,"askSize":200,"bidPrice":27.95,"bidSize":50,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":34.4051,"sharesOutstanding":360000,"nav":34.566084000000004,"aum":13826433.6,"dividendRate":0.002372,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.8186,"preClose":34.8186,"latestTime":"16:10 EDT","volume":6,"amount":208.83439799999996,"timestamp":1787688604015,"change":0,"changeRate":0,"amplitude":0.001109},"volumeRatio":0.415782,"impliedVol":0.3098,"impliedVolPercentile":0.7888},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.415782,"shares":400000,"dividePrice":0.0826,"high":34.86,"amplitude":0.002907,"preClose":34.4051,"low":34.76,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":34.8186,"committee":-0.6,"eps":0,"divideRate":0.002372,"volume":1685,"delay":0,"ttmEps":0,"open":34.76,"prevYearClose":30.32,"prevWeekClose":34.5867,"prevMonthClose":30.9904,"prevQuarterClose":30.62,"fiveDayClose":32.666,"twentyDayClose":31.4008,"sixtyDayClose":28.7305},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1108479803","title":"Jiangsu Hengrui Pharma Secures Clinical Trial Approval for Innovative Multi-Peptide Drug HRS-4729 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1108479803","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108479803?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:44","pubTimestamp":1786524272,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (SHA: 600276) has announced receiving the Drug Clinical Trial Approval Notice from the National Medical Products Administration (NMPA) for its HRS-4729...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2580892862.HKD","LU1997245177.USD","LU2495084118.USD","PSYK","LU1997244956.HKD","LU2543165471.USD","LU1820825898.SGD","LU0359201612.USD","LU1023057109.AUD","LU0405327494.USD","BK0028","LU1580142542.USD","LU2097828474.EUR","LU2328871848.SGD","LU2097828714.EUR","LU1328615791.USD","LU1255011170.USD","LU0359202008.SGD","LU0405327148.USD","LU1064131003.USD","LU2097828631.EUR","IBBQ","BK0188","LU2488822045.USD","LU1064130708.USD","LU1655091616.SGD","BK1191","BK0183","LU0359201885.HKD","LU2097828557.USD","LU2148510915.USD","LU1997245094.SGD","01276","BK0012","BK0196","BMED","LU2097828805.USD","BK0060","LU1781817850.SGD","BK0239","LU2580892789.USD","600276","LU1969619763.USD","MDTX","LU1146622755.USD","IBBJ","LU2289578879.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163630513","title":"Chengdu Easton Biopharma Subsidiary Initiates Phase I/II Trial for Novel Lymphoma Drug, First Patient Dosed","url":"https://stock-news.laohu8.com/highlight/detail?id=1163630513","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163630513?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:36","pubTimestamp":1786523800,"startTime":"0","endTime":"0","summary":"Chengdu Easton Biopharmaceuticals Co.,Ltd. (688513.SH) has announced that its majority-owned subsidiary, Shanghai Chaoyang Pharmaceutical Co., Ltd., has commenced a Phase I/II clinical trial for its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","IBBQ","688513","BK4092","PSYK","BK0239","BMED","MDTX","HP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177259314","title":"Haisco Pharmaceutical Group Receives Clinical Trial Approval for Novel Drug HSK60002 Tablet","url":"https://stock-news.laohu8.com/highlight/detail?id=1177259314","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177259314?lang=en_us&edition=fundamental","pubTime":"2026-08-12 15:54","pubTimestamp":1786521254,"startTime":"0","endTime":"0","summary":"Haisco Pharmaceutical Group Co.,Ltd. (002653.SZ) announced that it has received a Drug Clinical Trial Approval Notice from the National Medical Products Administration. The review found that the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","MDTX","BK0077","MEDX","06978","BK1161","BMED","BK0188","LNGR","BK0239","BK1574","159992","IBBQ","BK0028","BK0033","002653","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658946551","title":"MacroGenics Rises on $10 Million Milestone Payment from Gilead","url":"https://stock-news.laohu8.com/highlight/detail?id=2658946551","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658946551?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:17","pubTimestamp":1786483066,"startTime":"0","endTime":"0","summary":"BUZZ-MacroGenics rises on $10 million milestone payment from Gilead** Shares of drug developer MacroGenicsMGNX.Orise 3.8% to $4.07 in extended trading** Company says it has received a $10 million mile","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N4481HW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0965509010.AUD","LU1585245621.USD","LU1934455863.HKD","LU0114720955.EUR","IBB","LU1066051498.USD","LU0109394709.USD","LU1066053197.SGD","SG9999015945.SGD","BK4550","LU0889565916.HKD","IE00B3T34201.USD","BK4583","IE00B7SZLL34.SGD","LU0965509101.SGD","LU0823416689.USD","LU1430594728.SGD","LU2112291526.USD","LU2324357040.USD","TMED","GILD","LU0882574055.USD","BMED","LU0234570918.USD","LU1037948541.HKD","LU1037948897.HKD","LU1674673691.USD","LU1934455194.USD","LU2468319806.SGD","IE00B19Z3581.USD","LU1057294990.SGD","MGNX","BK4585","IBBQ","BBH","LU1839511570.USD","LU2089984988.USD","LU2087621335.USD","LU0965508806.USD","LU0965509283.SGD","SG9999015952.SGD","LU1571399168.USD","IE00BSNM7G36.USD","TBXU","MEDI","BIB","LU1023059063.AUD","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658294688","title":"Edwards Lifesciences CVP TAVR Daniel J. Lippis Melepas 619 Saham Senilai $ 56.966,57","url":"https://stock-news.laohu8.com/highlight/detail?id=2658294688","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658294688?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:08","pubTimestamp":1786482526,"startTime":"0","endTime":"0","summary":"Edwards Lifesciences CVP TAVR Daniel J. Lippis melepas 619 saham senilai $ 56.966,57Edwards Lifesciences: Daniel J. Lippis, CVP TAVR, menjual 619 saham pada 11 Agustus 2026 di harga USD 92,03.Transaks","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL6Dm4c4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Edwards Lifesciences CVP TAVR Daniel J. Lippis Melepas 619 Saham Senilai $ 56.966,57","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","IE00BN0W2V16.EUR","LU0058720904.USD","SG9999001176.SGD","AGNG","IE00BN0W2W23.USD","BK4082","LU0345774391.USD","BK4585","BK4504","BK4588","LU0289739699.SGD","LU0823416689.USD","EW","BMED","IE00BFXG0V08.USD","SGXZ57979304.SGD","SG9999013999.USD","IE00BN0W2T93.GBP","IHI","IE00BYQQ9H92.USD","SG9999001176.USD","LU0345774631.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":13,"totalSize":245,"code":"91000000","status":"200"}]}}